0001213900-24-059878.txt : 20240708 0001213900-24-059878.hdr.sgml : 20240708 20240708174627 ACCESSION NUMBER: 0001213900-24-059878 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240703 FILED AS OF DATE: 20240708 DATE AS OF CHANGE: 20240708 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Weisman Harlan F CENTRAL INDEX KEY: 0001555563 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39102 FILM NUMBER: 241105932 MAIL ADDRESS: STREET 1: C/O CORONADO BIOSCIENCES, INC. STREET 2: 15 NEW ENGLAND EXECUTIVE PARK CITY: BURLINGTON STATE: MA ZIP: 01803 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: TFF Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001733413 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 824344737 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2600 VIA FORTUNA, SUITE 360 CITY: AUSTIN STATE: TX ZIP: 78746 BUSINESS PHONE: 737-802-1973 MAIL ADDRESS: STREET 1: 2600 VIA FORTUNA, SUITE 360 CITY: AUSTIN STATE: TX ZIP: 78746 4 1 ownership.xml X0508 4 2024-07-03 0 0001733413 TFF Pharmaceuticals, Inc. TFFP 0001555563 Weisman Harlan F 1751 RIVER RUN, SUITE 400 FORT WORTH TX 76107 1 1 0 0 President and CEO 0 Common Stock 2024-07-03 4 A 0 27480 0 A 842095 D Stock Options (Right to Buy) 1.82 2024-07-03 4 A 0 27480 0 A 2025-06-19 2034-07-03 Common Stock 27480 27480 D Represents shares of common stock underlying restricted stock units ("RSUs"). Each RSU entitles its holder to receive one share of common stock of the issuer. The RSUs vest and settle in sixteen equal quarterly installments with a one-year cliff. One-quarter of the options vest and first become exercisable on June 19, 2025 and the remainder of the options vest and first become exercisable in 12 equal quarterly installments commencing on September 19, 2025. /s/ Harlan F. Weisman, by Kirk Allen Coleman, as Attorney-in-Fact 2024-07-05